genesis. Thus, intramuscular injections of large quantities of iron induce injection site sarcomas (6). the promotion process also increased both tumor yield and the To investigate the effect of iron on the development of incidence of colon cancer (11). mammary tumors, female Sprague-Dawley rats were given
Introduction

Treatment
Iron is an essential element, but too much and too little of it may
The experimental design used in the present study is shown in Figure 1. have adverse health consequences. Several epidemiological Specifically, rats were randomized into four groups of 30 each. At 55 days of studies suggest that an excess of body iron stores could age, rats in experimental groups (groups 1 and 2) received i.g. administration increase the risk of cancer (1) (2) (3) (4) . Iron overload can result from of 5 mg DMBA/kg body wt in olive oil. Controls (group 3) received equivalent volumes of olive oil only. Eight days later, animals in groups 2 and 3 received ingestion, inhalation, injection or a pathophysiologic process s.c. injections of iron (ferrous sulfate; 50 µmol/kg) twice a week for 53 weeks. (5) (6) (7) (8) . Iron may increase the risk at some cancer sites and not Ferrous sulfate was dissolved in argon purged saline and administered s.c. to others (7, 9) . A positive association has been observed between facilitate complete absorption of the administered dose. Group 4 was an body iron-stores and cancers of the liver, lung and intestine, untreated control group. The size and location of the tumor masses were while cancer of the stomach appeared to be unrelated to iron recorded every week starting from the first appearance of tumor. Sizes were recorded as diameter of the widest part of the tumor.
status (reviewed in 1). The tumors are often associated with the sites of deposition of the metal.
Necropsy and histopathology
Experimental evidence suggests that animals with high body Dead and moribund rats, and rats with tumor masses Ͼ5 cm, were necropsied. All remaining animals were killed at 62 weeks of age (i.e. 54 weeks after iron stores tend to be at greater risk than normal animals in initiation). Body weights were recorded and all mammary masses and normal the development of neoplasms. Evidence exists associating mammary glands were removed and weighed. Portions of mammary masses iron with both initiating and promoting phases of carcinoand spleens were frozen in liquid nitrogen for future molecular studies. Remaining portions of mammary masses, and all other tissues with lesions, were fixed in 10% neutral buffered formalin, trimmed and embedded in *Abbreviations: DMBA, 7,12-dimethylbenz[a]anthracene; NMU, N-nitrosomethylurea; SD, Sprague-Dawley; H&E, hematoxlin and eosin.
paraffin. Mammary tumors were classified as fibroadenomas, adenomas and adenocarcinomas using the criteria described by Young and Hallowes (15). Tissue sections were stained with hematoxlin and eosin (H&E). To detect ferric ions, selected sections of normal, hyperplastic and malignant mammary tissues were subjected to Gomori's modified iron/Prussian blue reaction (16).
Statistical analysis
Fisher's exact test was used in pair-wise comparison of incidence of mammary tumors. Data on body weight gain, tumor size and multiplicity (number of tumors/tumor-bearing rat) of tumors were examined by Dunnet's t-test and Kruskal-Wallis non-parametric ANOVA test. In all cases, a probability of Fig. 4 . Incidence of mammary tumors initiated by DMBA and promoted by P Ͻ 0.05 was considered to indicate a significant difference.
iron in female SD rats.
Results
with control groups). Although the survival in the DMBA/iron Body weight gain and survival group was more severely affected than in the DMBA-only Body weight gains were not significantly different between group, the difference was not of statistical significance. different groups of rats ( Figure 2 ). However, from week 30 to
Mammary tumors week 50, body weight gain in the DMBA/iron group was slightly but consistently lower than that in the saline-treated Mammary tumors started to appear 7-10 weeks after DMBA initiation. The first such tumor was seen in the DMBA/iron group.
Survival was moderately affected in rats exposed to iron sulfate group at 109 days of age (i.e.~6.5 weeks following DMBA administration). Although the tumor incidence following DMBA initiation (Figure 3) . A significant difference in the survival rate between the DMBA/iron group and two increased thereafter in both experimental groups, the increase was more pronounced in the iron-treated animals than in the control (iron-only and untreated) groups was observed after week 40 (P ϭ 0.03). Survival was also significantly affected DMBA-only group ( Figure 4) . Thus, at 35 weeks after treatment with DMBA, the mammary tumor incidence was significantly in the DMBA-only group after week 50 (P ϭ 0.03 compared higher (P ϭ 0.001) in the DMBA/iron group than in the DMBA-only group. The tumor incidence in the DMBA/iron group increased further as the promoter treatment continued and reached almost 90% at week 50 following DMBA initiation (P ϭ 0.0001 as compared with the DMBA-only group). A small number of rats (4/30; 13%) in the iron-only group also developed mammary tumors (Figure 4 ), while such tumors occurred in only one untreated control rat. The incidence of mammary tumors in the DMBA-only group was significantly higher than in the iron-only group after~30 weeks of promoter treatment. Injection site sarcomas, found in two rats given iron only group and one rat in the DMBA/iron group, were not included in Figure 4 .
Although the size of mammary tumors increased over time for DMBA-only rats between 20 and 50 weeks (9.0 Ϯ 1.9 versus 22.2 Ϯ 3.6; P ϭ 0.03) and DMBA/iron rats between 10 and 50 weeks (10.0 Ϯ 2.9 versus 24.7 Ϯ 2.06; P ϭ 0.01), the mean diameters of these tumors in DMBA/iron rats were consistently larger than in DMBA-only rats ( Figure 5 ). Thus, mammary tumors in DMBA/iron rats were 2.3 times (P ϭ 0.04) larger than those in DMBA-only rats at 20 weeks and tumors between DMBA/iron and DMBA-only groups was not statistically significant. Figure 7 ). The incidence of mammary adenocarcinomas in Multiple mammary tumors occurred mostly in DMBA-DMBA-only and DMBA/iron groups was significantly higher initiated animals. No significant differences were seen in the than in the iron-only group (P ϭ 0.04). Mammary tumors in multiplicity of mammary tumors between DMBA-only and iron-only group included three fibroadenomas (50%), two DMBA/iron groups at any observation time point (data not adenomas (30%) and one adenocarcinoma (20%). Two shown). However, at 53 weeks (i.e. at 62 weeks of age) when mammary tumors, a fibroadenoma and an adenocarcinoma the experiment was terminated, the multiplicity of such tumors occurred in one untreated control rat (data not shown). was greater in the DMBA-only and the DMBA/iron groups as Detection of iron (Gomori's technique) compared with the iron-only group, a difference close to statistical significance (P ϭ 0.07; Figure 6 ).
Gomori's technique was used to detect iron in different histological components of mammary gland tumors. It is clear Mammary tumors in the DMBA-only and DMBA/iron groups were mostly adenomas and adenocarcinomas (85-88%;
from Figure 8A that no iron was detectable by this technique lial cells of mammary adenocarcinomas ( Figure 8D) 21) . Thus, the alterations in iron sequestration observed during the progression from normal to hyperplastic and benign lesions appear to depend upon the cell types altered. cancer cells will survive and flourish (1). The histological findings of mammary glands and mammary tumors reported here, as well as in earlier studies (13) , indicated significant in mammary adenocarcinomas induced by DMBA alone. It differences in iron distribution within these tissues during should be noted here that this histochemical method may not mammary carcinogenesis. Of particular interest was the total detect all forms of bound iron and some undetected iron may absence of iron deposits in the malignant epithelial cells and be present in the neoplastic cells. Iron was, however, easily its preferential accumulation in the stroma surrounding the detectable by this method in the stromal tissue and hyperplastic adenocarcinomas. Similar findings were reported in Hodgkin's mammary glands initiated by DMBA and promoted by iron disease by Smithyman et al. (24) who observed heavy deposits ( Figure 8B ). As shown earlier by Singh et al. (13) , epithelial of ferritin and iron at the periphery of the tumor nodules. It cells from benign mammary tumors (adenomas) were positive is suggested that the accumulation of iron around the neoplasms for iron ( Figure 8C ) but malignant epithelial cells were devoid possibly could be induced by the tumor cells to ensure a of such ions ( Figure 8D ). However, iron was detectable in the supply of this growth essential metal (1). This high iron stromal tissue adjacent to adenocarcinomas.
requirement by the neoplastic cells may be related to their rapid rate of proliferation and high levels of transferrin-binding Discussion glycoproteins on their cell surfaces (25-27). Thus, transformed lymphoid cell lines have as many as 1000 times the number The results of our study clearly show that iron administered s.c. as ferrous sulfate exhibits a strong promoting activity for of transferrin receptors found on normal resting lymphocytes (28). It would be interesting to determine whether such mammary tissue in female SD rats. This promoting effect is evident from the fact that the administration of this metal differences in the number of receptors occur between the normal, preneoplastic and neoplastic mammary cells in rats following DMBA initiation greatly shortened the latency period for mammary tumor appearance and significantly increased exposed to iron following DMBA treatment. Also, since some siderophores (low molecular weight peptides involved in their incidence as compared with rats not receiving such treatment. Also, the size of mammary tumors in iron-promoted iron transport) have been shown to inhibit iron uptake from transferrin and produce anti-proliferative (and anti-tumor) rats was consistently larger than in DMBA-only rats until the final observation time point at 54 weeks after initiation. The effects in several in vitro and in vivo systems (29-31), it may be worthwhile to initiate further studies to examine the effects occurrence of a small incidence of mammary tumors in noninitiated rats in this study is not totally surprising since the of such chelators on iron uptake and tumor development in the rat mammary gland. feeding of other established rat tumor promoters, phenobarbital alone or sodium barbital alone, similarly elicits a low incidence Second, iron can catalyze the induction of oxygen radicals. In all aerobic organisms, iron as a divalent cation plays an of liver and/or renal tumors in rats (17,18).
Iron was not detectable histochemically in normal mammary important role in a series of reactions referred to as the Fenton Haber-Weiss cycle. Products of these reactions (i.e. hydroxyl glands of iron-treated animals. It could be detected in both DMBA-initiated and spontaneous hyperplastic mammary tissue radicals and other oxidants) have been shown to cause DNA strand breaks and mutagenicity (32, 33) . It is now widely suggesting an altered physiologic state. Iron was also detectable in the epithelial cells of benign tumors, i.e. fibroadenomas believed that many tumor promoters commonly exert their effect in part through the accumulation of free radicals (34, 35) . and adenomas ( Figure 8C ). The significance of such focal accumulation of iron and the nature of its transportation (as Hydroxyl radicals also deplete intracellular stores of anticarcinogens including anti-oxidant enzymes and low molecular well as binding) to preneoplastic mammary tissues is not yet clear (1, 19) .
weight scavenger molecules (36) . Thus, preferential accumulation of iron in hyperplastic mammary glands and the subsequent Interestingly, however, iron was not detectable in the epithe- Although Western diets include red meat, as well as widely of effect of phenobarbital, amobarbital, or barbituric acid on development used vitamin supplements, are very rich in iron (37, 38) 
